Compare ECF & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ECF | OSUR |
|---|---|---|
| Founded | 1986 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 167.1M | 177.2M |
| IPO Year | N/A | 1986 |
| Metric | ECF | OSUR |
|---|---|---|
| Price | $11.68 | $2.40 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $3.00 |
| AVG Volume (30 Days) | 57.7K | ★ 742.3K |
| Earning Date | 01-01-0001 | 11-05-2025 |
| Dividend Yield | ★ 6.42% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.46 | N/A |
| Revenue | N/A | ★ $125,703,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $3.70 |
| P/E Ratio | $17.61 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $7.02 | $2.08 |
| 52 Week High | $8.91 | $4.22 |
| Indicator | ECF | OSUR |
|---|---|---|
| Relative Strength Index (RSI) | 46.79 | 43.86 |
| Support Level | $11.31 | $2.41 |
| Resistance Level | $12.05 | $2.53 |
| Average True Range (ATR) | 0.20 | 0.11 |
| MACD | -0.03 | 0.01 |
| Stochastic Oscillator | 45.95 | 15.52 |
Ellsworth Growth and Income Fund Ltd operate as a closed-end, diversified management investment company. Its investment objective is to provide income and the potential for capital appreciation, which objectives the Fund considers to be relatively equal over the long term due to the nature of the securities in which it invests. The company invests in convertible and equity securities. It invests in various sectors, such as healthcare, financial services, computer software and services, energy and utilities, real estate investment trusts, semiconductors, telecommunications, business services, food and beverage, consumer products, transportation, consumer services among others.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.